Raptor Pharmaceuticals Overview
- Status
-
Acquired/Merged
- Employees
-
182
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
7
Raptor Pharmaceuticals General Information
Description
Provider of bio-pharmaceutical therapies intended to treat diseases that are debilitating and life-threatening. The company's bio-pharmaceutical therapies focuses on developing and commercializing therapies to treat debilitating and often fatal diseases for Huntington's disease, non-fatty liver disease, primary liver cancer & other cancers.
Contact Information
Website
www.raptorpharma.comCorporate Office
- 7 Hamilton Landing
- Suite 100
- Novato, CA 94949
- United States
Corporate Office
- 7 Hamilton Landing
- Suite 100
- Novato, CA 94949
- United States
Raptor Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Raptor Pharmaceuticals Comparisons
Industry
Financing
Details
Raptor Pharmaceuticals Competitors (133)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Merck & Co. | Corporation | Rahway, NJ | 00000 | 0000 | 000000000 - | 0000 |
Astellas Pharma | Corporation | Tokyo, Japan | 00000 | 00000000 | ||
Amylyx | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
XBiotech | Corporation | Austin, TX | 00 | 0000 | 00000000 | 0000 |
Ironwood Pharmaceuticals | Formerly VC-backed | Boston, MA | 000 | 00000 | 000000000 | 00000 |
Raptor Pharmaceuticals Signals
Raptor Pharmaceuticals Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Raptor Pharmaceuticals Investments & Acquisitions (7)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Quinsair | 05-Oct-2015 | 0000000000 | 00000 | Pharmaceuticals | 00000 000 |
TorreyPines Therapeutics | 28-Sep-2009 | 0000000000 | Biotechnology | 000 00000 | |
Convivia (ALDH2 deficiency product) | 21-Apr-2008 | 0000000000 | Buildings and Property | ||
University of California, San Diego (worldwide license to intellectual property of Cysteamine) | 19-Mar-2008 | 000000000 | Buildings and Property | ||
CalciMedica | 23-Jan-2008 | Early Stage VC | 00.000 | Drug Discovery |
Raptor Pharmaceuticals FAQs
-
Who is the founder of Raptor Pharmaceuticals?
Todd Zankel is the founder of Raptor Pharmaceuticals.
-
Where is Raptor Pharmaceuticals headquartered?
Raptor Pharmaceuticals is headquartered in Novato, CA.
-
What is the size of Raptor Pharmaceuticals?
Raptor Pharmaceuticals has 182 total employees.
-
What industry is Raptor Pharmaceuticals in?
Raptor Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Raptor Pharmaceuticals a private or public company?
Raptor Pharmaceuticals is a Private company.
-
What is the current valuation of Raptor Pharmaceuticals?
The current valuation of Raptor Pharmaceuticals is 00000.
-
What is Raptor Pharmaceuticals’s current revenue?
The current revenue for Raptor Pharmaceuticals is 000000.
-
How much funding has Raptor Pharmaceuticals raised over time?
Raptor Pharmaceuticals has raised $17.1M.
-
Who are Raptor Pharmaceuticals’s investors?
Great Point Partners, Heights Capital Management, Patricia Industries, RiverVest Venture Partners, and Synthesis Capital (Boston) have invested in Raptor Pharmaceuticals.
-
Who are Raptor Pharmaceuticals’s competitors?
Merck & Co., Astellas Pharma, Amylyx, XBiotech, and Ironwood Pharmaceuticals are some of the 133 competitors of Raptor Pharmaceuticals.
-
When was Raptor Pharmaceuticals acquired?
Raptor Pharmaceuticals was acquired on 25-Oct-2016.
-
Who acquired Raptor Pharmaceuticals?
Raptor Pharmaceuticals was acquired by Horizon Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »